{"nctId":"NCT00282984","briefTitle":"Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking","startDateStruct":{"date":"2006-02"},"conditions":["Smoking Cessation"],"count":714,"armGroups":[{"label":"placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: placebo"]},{"label":"varenicline","type":"EXPERIMENTAL","interventionNames":["Drug: Varenicline"]}],"interventions":[{"name":"placebo","otherNames":[]},{"name":"Varenicline","otherNames":["Chantix, Champix"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Participants must have stable, documented cardiovascular disease (including at least one of the following diagnosed \\> 2 months prior to the Screening visit - angina, myocardial infarction (MI), revascularization, transient ischemic attack (TIA), and peripheral vascular disease (PVD).\n* Participants that smoke \\> 10 cigarettes / day.\n\nExclusion Criteria:\n\n* Participants with unstable cardiovascular disease\n* Cardiovascular events in the past 2 months\n* Moderate or severe chronic obstructive pulmonary disease (COPD)","healthyVolunteers":false,"sex":"ALL","minimumAge":"35 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Responders With Carbon Monoxide (CO) Confirmed 4-week Continuous Quit Rate (CQR) for Last 4 Weeks of Treatment (Trtmt)","description":"Participants considered Responders (4-week CQR \\<=10 parts per million \\<ppm\\>) through reports of cigarette or other nicotine use since last study visit, confirmed by measurement of end-expiratory exhaled carbon monoxide (CO). If any CO measurement at a particular timepoint was \\>10 ppm, subject was considered to be Non-Responder at that timepoint.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"167","spread":null},{"groupId":"OG001","value":"50","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"186","spread":null},{"groupId":"OG001","value":"300","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Responders With Continuous Abstinence (CA) Through Week 52","description":"Responders: participants who remained abstinent based on 'since the last contact' question in Nicotine Use Inventory 1) \"Has participant smoked any cigarettes (even a puff) since last contact?\" = No AND 2) \"Has participant used any other tobacco products… since last contact?\" = No. Participant a non-responder if expired CO \\> 10 ppm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70","spread":null},{"groupId":"OG001","value":"26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"283","spread":null},{"groupId":"OG001","value":"324","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Long-Term Quit Responders","description":"Responders: participants were considered Long Term Quit responders if 1) they were responders for the primary endpoint (the 4-week CQR for Weeks 9-12) and 2) had no more than 6 days of smoking from Week 12 through the given visit.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"80","spread":null},{"groupId":"OG001","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"273","spread":null},{"groupId":"OG001","value":"316","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Seven-Day Point Prevalence of Abstinence at Week 12","description":"Responders: abstinence in previous seven days, defined in the non-treatment follow-up as: 1) \"Has the participant smoked any cigarettes in the last 7 days?\" = No AND 2) \"Has the participant used any other tobacco products in the last 7 days?\" = No. Participant a non-responder if expired CO \\> 10 ppm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"192","spread":null},{"groupId":"OG001","value":"65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"161","spread":null},{"groupId":"OG001","value":"285","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Seven-Day Point Prevalence of Abstinence at Week 24","description":"Responders: abstinence in previous seven days, defined in the non-treatment follow-up as: 1) \"Has the participant smoked any cigarettes in the last 7 days?\" = No AND 2) \"Has the participant used any other tobacco products in the last 7 days?\" = No. Participant a non-responder if expired CO \\> 10 ppm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"124","spread":null},{"groupId":"OG001","value":"57","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"229","spread":null},{"groupId":"OG001","value":"293","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a Seven-Day Point Prevalence of Abstinence at Week 52","description":"Responders: abstinence in previous seven days, defined in the non-treatment follow-up as: 1) \"Has the participant smoked any cigarettes in the last 7 days?\" = No AND 2) \"Has the participant used any other tobacco products in the last 7 days?\" = No. Participant a non-responder if expired CO \\> 10 ppm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"102","spread":null},{"groupId":"OG001","value":"62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"251","spread":null},{"groupId":"OG001","value":"288","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With a 4 Week Point Prevalence of Smoking Cessation","description":"Responders: participants with abstinence during the last 4 weeks of non-treatment based on answering 'no' to both of the two 'last 4 week' questions in the Nicotine Use Inventory (NUI). NUI collected information of cigarette or other nicotine use during the study.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"99","spread":null},{"groupId":"OG001","value":"57","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Responders With Continuous Abstinence (CA) Through Week 24","description":"Responders: participants who remained abstinent based on 'since the last contact' question in Nicotine Use Inventory 1) \"Has participant smoked any cigarettes (even a puff) since the last contact?\" = No AND 2) \"Has participant used any other tobacco products… since the last contact?\" = No. Non- responder if the expired CO \\> 10 ppm at any given timepoint.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"34","spread":null}]}]}]},{"type":"SECONDARY","title":"Cigarettes Smoked Per Day","description":"Cigarettes smoked each day during the first 3 weeks of the treatment phase.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.2","spread":"10.0"},{"groupId":"OG001","value":"22.9","spread":"10.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.6","spread":"9.4"},{"groupId":"OG001","value":"19.1","spread":"10.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.8","spread":"8.8"},{"groupId":"OG001","value":"18.4","spread":"9.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.8","spread":"9.2"},{"groupId":"OG001","value":"18.0","spread":"10.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.7","spread":"8.9"},{"groupId":"OG001","value":"17.1","spread":"9.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"15.1","spread":"8.8"},{"groupId":"OG001","value":"16.3","spread":"8.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.4","spread":"8.4"},{"groupId":"OG001","value":"16.0","spread":"8.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.8","spread":"8.6"},{"groupId":"OG001","value":"15.1","spread":"8.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.7","spread":"9.2"},{"groupId":"OG001","value":"12.3","spread":"10.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.5","spread":"7.5"},{"groupId":"OG001","value":"10.9","spread":"9.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.9","spread":"7.2"},{"groupId":"OG001","value":"10.6","spread":"8.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.9","spread":"7.3"},{"groupId":"OG001","value":"10.4","spread":"8.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.7","spread":"7.5"},{"groupId":"OG001","value":"10.5","spread":"8.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":"7.1"},{"groupId":"OG001","value":"10.3","spread":"8.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.3","spread":"7.4"},{"groupId":"OG001","value":"10.7","spread":"8.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.9","spread":"7.6"},{"groupId":"OG001","value":"11.2","spread":"9.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.8","spread":"7.1"},{"groupId":"OG001","value":"11.0","spread":"8.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.3","spread":"6.4"},{"groupId":"OG001","value":"10.6","spread":"8.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.2","spread":"6.9"},{"groupId":"OG001","value":"10.3","spread":"8.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.8","spread":"6.7"},{"groupId":"OG001","value":"10.3","spread":"8.4"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.9","spread":"6.1"},{"groupId":"OG001","value":"10.6","spread":"8.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.2","spread":"6.3"},{"groupId":"OG001","value":"9.3","spread":"8.1"}]}]}]},{"type":"SECONDARY","title":"Number of Long-Term Quit Responders From Week 9 Through Week 24","description":"Responders: participants were considered Long Term Quit Responders if 1) they were responders for the primary endpoint (the 4-week CQR for Weeks 9-12) and 2) had no more than 6 days of smoking from Week 12 through the given visit.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"117","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"236","spread":null},{"groupId":"OG001","value":"308","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":23},"commonTop":["Nausea","Headache","Insomnia","Nasopharyngitis","Diarrhoea"]}}}